Contact CFFC


Clinical Trial Alerts – November 2018

Cystic Fibrosis Foundation distributed the following clinical trial update in November. Click the trial title to get more details.

This alert was issued on November 2nd:

IGNITE: Safety and effectiveness of gallium nitrate in adults with cystic fibrosis

Status: Completed with results

Description: This study evaluated the safety and effectiveness of intravenous (IV) gallium nitrate in adults with CF who are chronically infected with Pseudomonas aeruginosa.

Age: 18 Years and Older

Mutation: No Mutation Requirement

Fev1% Predicted: 25% or greater

Number of Visits: 5

Length of Participation: 63 days link:

Comments are closed.